Filing Details
- Accession Number:
- 0001209191-14-043939
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-06-26 20:08:09
- Reporting Period:
- 2014-06-24
- Filing Date:
- 2014-06-26
- Accepted Time:
- 2014-06-26 19:08:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 353569 | Quidel Corp | QDEL | In Vitro & In Vivo Diagnostic Substances (2835) | 942573850 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1222788 | John Tamerius | 10165 Mckellar Court San Diego CA 92121 | Svp - Clinical/Reg Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-06-24 | 5,000 | $23.06 | 30,766 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The weighted average purchase price for these transactions was $23.064 per share, with a range of $22.85 to $23.26 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
